Antimicrobial Protection
BioCote® is an antimicrobial silver additive used to limit the numbers of microbes on the surface of breathing circuits.
Search
Systemy NeoFlow® do wysokoprzepływowej tlenoterapii donosowej (nHFOT) i terapii CPAP dla noworodków
Systemy NeoFlow® do tlenoterapii wysokoprzepływowej umożliwiają łatwe zamienne stosowanie terapii nCPAP, bąbelkowej CPAP oraz wentylacji inwazyjnej.
Failure to Oxygenate HFOT & CPAP Delivered by AquaVENT FD140i® Provides the Solution
St Bartholomew’s has several AquaVENT® FD140i devices and they ‘use every one of them’. The nurses, outreach team, and medical staff find the AquaVENT® FD140i highly effective in the delivery of HFOT and CPAP.
Bridging the Gap in CPAP Therapy: Supporting Children of All Ages with AquaVENT® FD140i
With the AquaVENT® FD140i we are now able to deliver full facial CPAP for all ages, therefore being able to care for a larger cohort of patients.
Launching AquaVENT® VT at Arab Health 2022
Intuitive Moisture Management with state-of-the-art technology.
AquaVENT® FD140i now available in the Philippines
Healthsolutions launch innovative dual therapy device.
Launching AquaVENT® VT at Medica 2021
Intuitive Moisture Management with state-of-the-art technology.
Advanced Respiratory Care Centre Specialises in the Use of HFOT and CPAP to Treat Hypoxic Patients
The Mater Misericordiae now has 30 AquaVENT® FD140i devices and they ‘use every one of them’. The nurses find the AquaVENT® FD140i highly effective in the delivery of HFOT and CPAP.
Reducing ICU Post-Op Admissions Delivery CPAP Therapy in Recovery
Dr Jubil Thomas, demonstrated the ability of HFOT and CPAP using the AquaVENT® FD140i to adequately oxygenate patients both pre and postoperatively, with the potential to improve throughput within the theatres and reduce postoperative ICU admissions.
Pre-Oxygenation: A Solution to Effectively Pre-Oxygenating Patients
We have now taken delivery of our first AquaVENT ® FD140i, prior to this we had no functional device available in our institution which brought the potential risk of perioperative hypoxic injury to our patients.
Antimicrobial Protection
BioCote® is an antimicrobial silver additive used to limit the numbers of microbes on the surface of breathing circuits.
Systemy NeoFlow® do wysokoprzepływowej tlenoterapii donosowej (nHFOT) i terapii CPAP dla noworodków
Systemy NeoFlow® do tlenoterapii wysokoprzepływowej umożliwiają łatwe zamienne stosowanie terapii nCPAP, bąbelkowej CPAP oraz wentylacji inwazyjnej.
Failure to Oxygenate HFOT & CPAP Delivered by AquaVENT FD140i® Provides the Solution
St Bartholomew’s has several AquaVENT® FD140i devices and they ‘use every one of them’. The nurses, outreach team, and medical staff find the AquaVENT® FD140i highly effective in the delivery of HFOT and CPAP.
Bridging the Gap in CPAP Therapy: Supporting Children of All Ages with AquaVENT® FD140i
With the AquaVENT® FD140i we are now able to deliver full facial CPAP for all ages, therefore being able to care for a larger cohort of patients.
Launching AquaVENT® VT at Arab Health 2022
Intuitive Moisture Management with state-of-the-art technology.
AquaVENT® FD140i now available in the Philippines
Healthsolutions launch innovative dual therapy device.
Launching AquaVENT® VT at Medica 2021
Intuitive Moisture Management with state-of-the-art technology.
Advanced Respiratory Care Centre Specialises in the Use of HFOT and CPAP to Treat Hypoxic Patients
The Mater Misericordiae now has 30 AquaVENT® FD140i devices and they ‘use every one of them’. The nurses find the AquaVENT® FD140i highly effective in the delivery of HFOT and CPAP.
Reducing ICU Post-Op Admissions Delivery CPAP Therapy in Recovery
Dr Jubil Thomas, demonstrated the ability of HFOT and CPAP using the AquaVENT® FD140i to adequately oxygenate patients both pre and postoperatively, with the potential to improve throughput within the theatres and reduce postoperative ICU admissions.
Pre-Oxygenation: A Solution to Effectively Pre-Oxygenating Patients
We have now taken delivery of our first AquaVENT ® FD140i, prior to this we had no functional device available in our institution which brought the potential risk of perioperative hypoxic injury to our patients.
